Home·Stocks·ABSI
Absci Corporation Common Stock

ABSI

XNAS

Absci Corporation Common Stock

Industrials · Services-Commercial Physical & Biological Research

$5.29
-0.06 (-1.12%)
15-min delayed

Drag to pan · Scroll to zoom · Hover for OHLC

Snapshot
Loading metrics…
About Absci Corporation Common Stock

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Employees
140
Country
US
IPO Date
2021-07-22
www.absci.com →
Recent News
AMD Reveals A $6.5 Million Marvell Bet That's Already Soaring
Benzinga · 6h ago
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine
SeekingAlpha · 5d ago
Truist Securities Maintains Buy on Absci, Raises Price Target to $11
Benzinga · 5d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 5d ago
Absci Corporation (ABSI) Q1 2026 Earnings Call Transcript
SeekingAlpha · 5d ago
Transcript : Absci Corporation, Q1 2026 Earnings Call, May 07, 2026
Finnhub · 5d ago
Absci Corp (NASDAQ:ABSI) Plunges on 86% Q1 Revenue Miss Despite Clinical Advances
ChartMill · 5d ago
Absci Q1 EPS $(0.19) Beats $(0.23) Estimate, Sales $215.000K Miss $1.550M Estimate
Benzinga · 6d ago
Analyst Ratings
Loading…
Financials
Loading SEC filings…
Insider Activity
Loading filings…
Related Stocks
Loading peers…
Ask AI about ABSIBuild basket with ABSIScreener

Data is 15-minute delayed, for informational purposes only. Not investment advice. Prices via Massive.com consolidated feed. Fundamentals via FinancialModelingPrep. News via Finnhub.